• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. INTERSTIM II; STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE Back to Search Results
Model Number 3058
Device Problems Failure to Deliver Energy (1211); Insufficient Information (3190)
Patient Problems Pain (1994); Skin Irritation (2076); Therapeutic Effects, Unexpected (2099); Urinary Tract Infection (2120)
Event Date 04/01/2020
Event Type  Injury  
Manufacturer Narrative
Concomitant medical products: product id: a520, serial#: unknown, product type: software; product id: 3889-28, lot#: va1ynf3, implanted: (b)(6) 2019, product type: lead.Other relevant device(s) are: product id: 3889-28, serial/lot#: (b)(4), ubd: 07-mar-2023, udi#: (b)(4).Date is approximate with month/year validity.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a consumer regarding a patient with an implantable neurostimulator (ins) for urinary dysfunction/sacral nerve stimulation and gastrointestinal/pelvic floor.The patient reported that they were not sure if the lead or the device was acting up.The patient reported that the device was not helping with their symptoms.The patient reported they were not feeling stimulation and they were having pain where the lead was.The patient stating that they kept getting infections and their primary care health care physician (hcp) thought that the issue was the lead.The patient reported that the bladder infection moved to their lead and noted that their urine output had not changed.The patient reported that it was very sensitive where the lead was and stated that they didn¿t know if the lead moved or if the infection caused something.The patient reported that the handset shut off when they tried to change programs.While on the call, patient services had the patient turn the handset off and then back on and the patient was able to change programs.The patient was redirected to follow up with their hcp to have the device checked.There were no further complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTERSTIM II
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
david gustafson
7000 central avenue ne rcw215
minneapolis, MN 55432
7635149628
MDR Report Key10246427
MDR Text Key199272787
Report Number3004209178-2020-11803
Device Sequence Number1
Product Code EZW
UDI-Device Identifier00613994913654
UDI-Public00613994913654
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 07/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/14/2020
Device Model Number3058
Device Catalogue Number3058
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 07/06/2020
Initial Date FDA Received07/08/2020
Date Device Manufactured03/19/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age24 YR
-
-